학술논문
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
Document Type
Article
Author
Source
In: Gynecologic Oncology . (Gynecologic Oncology, February 2023, 169:64-69)
Subject
Language
English
ISSN
10956859
00908258
00908258